2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Memory Impairment: new trials by email Literature Review of Memory Impairment trials Research Report on Memory Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer's Disease COT, Sham - Mild Cognitive Impairment, Early Alzheimer's Disease | Phase 2 | Unknown | Evon Medics LLC | 200 | 2021-11-15 | 2022-05-17 |
| Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease Levetiracetam, Placebo - Parkinson Disease, Mild Cognitive Impairment | Phase 2 | Unknown | The University of Queensland | 28 | 2021-02-09 | 2024-09-25 |
Cognitive Dysfunction (2) · Memory Disorders (2) · Alzheimer Disease (1) · Parkinson Disease (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cognition Disorders (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurocognitive Disorders (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Basal Ganglia Diseases (1) · Dementia (1) · Movement Disorders (1) · Parkinsonian Disorders (1)
Levetiracetam (1) · salicylhydroxamic acid (1)
Evon Medics LLC (1) · The University of Queensland (1)
Australia (1) · United States (1)
R44AG061981 (1)